News and Accolades

Co-led by Gavin Arteel, PhD, the study demonstrates the potential of matrix-bound nanovesicles to protect against alcohol-related liver injury.

Faculty are contributing to more than 60 accepted abstracts at the American Association for the Study of Liver Diseases’ annual meeting, highlighting the breadth of Pitt’s liver disease research.

Dr. Jaideep Behari, the new Chief of Gastroenterology, Hepatology and Nutrition, discusses his unexpected path to hepatology, lessons from his year as interim chief, and his vision for the division’s future.

Following a national search, Behari has been appointed chief of the Division, where he has served as interim chief while advancing its clinical, research, and educational missions.

Research coauthored by Biggins found that liver transplant candidates denied MELD score exceptions for hepatocellular carcinoma had more aggressive tumor characteristics, reinforcing the importance of expert clinical review.

With Dr. Fei-Pi Lin as co-director, the program integrates liver and neurologic expertise to streamline diagnosis and treatment.

Scientists at the University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center developed BiliSeq, a molecular test that detected bile duct cancer with twice the sensitivity of the standard test, giving physicians a more accurate picture of the patient’s diagnosis.

By borrowing tools from rainforest ecology, Gavin Arteel, PhD, et al. identify patterns of gene expression collapse that may extend beyond alcohol-associated hepatitis to other chronic diseases.

Researchers from the Division of Gastroenterology, Hepatology and Nutrition at the University of Pittsburgh report that minor papillotomy does not reduce recurrence in patients with pancreas divisum.

The FORTE trial shows how large, prevention-focused studies can reshape care and how expanded support can grow clinical research across the DOM.